Aspen Pharmacare Holdings Ltd (APNJ.J)
19 Oct 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|49||2017||Non-Executive Chairman of the Board|
|53||2014||Group Chief Executive, Executive Director|
|56||Deputy Group Chief Executive, Executive Director|
|41||2013||Company Secretary & Group Governance Officer|
|69||2010||Lead Independent Non-Executive Director|
- Aspen Pharma suffers week of woe as valuation tumbles by $3 bln
- UPDATE 1-South Africa's rand firms on positive consumer inflation data
- UPDATE 1-Naspers frees cash-rich Multichoice to take on Netflix & co
- CORRECTED-Naspers frees cash-rich Multichoice to take on Netflix & co
- France's Lactalis gets go-ahead to reopen plant after tainted milk scandal